Pandemic danger to the deep: the risk of marine mammals contracting SARS-CoV-2 from wastewater
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
We are in unprecedented times with the ongoing COVID-19 pandemic. The pandemic has impacted public health, the economy and our society on a global scale. In addition, the impacts of COVID-19 permeate into our environment and wildlife as well. Here, we discuss the essential role of wastewater treatment and management during these times. A consequence of poor wastewater management is the discharge of untreated wastewater carrying infectious SARS-CoV-2 into natural water systems that are home to marine mammals. Here, we predict the susceptibility of marine mammal species using a modelling approach. We identified that many species of whale, dolphin and seal, as well as otters, are predicted to be highly susceptible to infection by the SARS-CoV-2 virus. In addition, geo-mapping highlights how current wastewater management in Alaska may lead to susceptible marine mammal populations being exposed to the virus. Localities such as Cold Bay, Naknek, Dillingham and Palmer may require additional treatment of their wastewater to prevent virus spillover through sewage. Since over half of these susceptibility species are already at risk worldwide, the release of the virus via untreated wastewater could have devastating consequences for their already declining populations. For these reasons, we discuss approaches that can be taken by the public, policymakers and wastewater treatment facilities to reduce the risk of virus spillover in our natural water systems. Thus, we indicate the potential for reverse zoonotic transmission of COVID-19 and its impact on marine wildlife; impacts that can be mitigated with appropriate action to prevent further damage to these vulnerable populations.
Article activity feed
-
SciScore for 10.1101/2020.08.13.249904: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Assessing the susceptibility of species to SARS-CoV-2: After compiling the mutation data for comparisons between human ACE2 and the orthologous ACE2 sequences, we utilized the MutaBind2 tool to model and predict whether these mutations (i) improve or (ii) reduce SARS-CoV-2 binding affinity to the receptor (Mihindukulasuriya, Wu, St Leger, Nordhausen, & Wang, 2008; Zhang et al., 2020). MutaBind2suggested: NoneWastewater treatment plant outfall location, treatment type, maximum daily flow, and name of receiving water body was assembled through permit search of the Alaska permit database … SciScore for 10.1101/2020.08.13.249904: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Assessing the susceptibility of species to SARS-CoV-2: After compiling the mutation data for comparisons between human ACE2 and the orthologous ACE2 sequences, we utilized the MutaBind2 tool to model and predict whether these mutations (i) improve or (ii) reduce SARS-CoV-2 binding affinity to the receptor (Mihindukulasuriya, Wu, St Leger, Nordhausen, & Wang, 2008; Zhang et al., 2020). MutaBind2suggested: NoneWastewater treatment plant outfall location, treatment type, maximum daily flow, and name of receiving water body was assembled through permit search of the Alaska permit database maintained through the Alaska Department of Environmental and Conservation. Conservationsuggested: (Conservation, RRID:SCR_016064)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
